Good News: Another coronavirus medicine in India . This injection will end COVID-19
Rahul Prakash, New Delhi: Indian pharmaceutical companies battling the coronavirus are gaining rapid success. Another coronavirus medicine has been approved in India. The drug maker Hetero says that it is going to launch the antiviral drug Remadecivir for the treatment of COVID-19. The company has already taken approval from the Drug Controller General of India (DGCI). This medicine is to be sold in India under the name Kovifor. Remadesiveer, which is being called the panacea for the coronavirus epidemic, will also reach India by the end of this month. The DCGI recently allowed the use of this drug in emergency cases for coronavirus patients. The DGCI has allowed the Indian pharmaceutical company Cipla and Hetero to manufacture and sell this medicine. According to the company, the DGCI has approved the use of this drug in the treatment of both suspected and confirmed patients of coronavirus. However, these injections can only be given to patients whose condition is critical. The c...